Stock Price Forecast

March 27, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Cidara Therapeutics Inc chart...

About the Company

cidara is a biotechnology company focused on the discovery, development, and commercialization of novel anti-infectives for the treatment of diseases that are inadequately addressed by current standard of care therapies. our first product candidate is cd101 iv, a potential once-weekly intravenous therapy being developed for the treatment and prevention of systemic fungal infections. our second product candidate, cd101 topical, is a topical formulation of cd101, the first topical application of the enchinocandin class of anti-fungals, for the treatment of vulvovaginal candidiasis, or vvc. in addition, we have developed a proprietary immunotherapy technology platform, cloudbreak™, which we use to create compounds designed to direct a patient’s immune cells to attack and eliminate pathogens that cause infectious disease. we are developing our first cloudbreak development candidate, c001, for the treatment of invasive aspergillosis.

CEO

Jeffrey Stein

Exchange

NASDAQ

Website

http://www.cidara.com/

$54M

Total Revenue

81

Employees

$77M

Market Capitalization

-2.58

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $CDTX News

Cidara Therapeutics gets grant for conjugates for treating viral infections

15h ago, source: Pharmaceutical Technology

Discover how Cidara Therapeutics' patented conjugates can revolutionize the treatment of viral infections, specifically influenza, with innovative compositions and methods.

Cidara Therapeutics Receives $11.14 Million Milestone Payment Following European Approval of REZZAYO

1mon ago, source: Business Insider

Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve ...

Cidara Therapeutics Granted Nasdaq Listing Extension

1mon ago, source: TipRanks on MSN

Cidara Therapeutics (CDTX) has released an update. Cidara Therapeutics, Inc. has been granted an extension by the Nasdaq ...

Cidara Therapeutics Inc (CDTX) Earnings Dates & Reports

24d ago, source: Investing

View upcoming earnings forecasts and in-depth analysis of company forecasts.

Cidara Therapeutics, Inc. (CDTX)

6d ago, source: Yahoo Finance

*Close price adjusted for splits.**Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...

Cidara Therapeutics Inc CDTX

9d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Cidara Therapeutics Inc.

12d ago, source: TheStreet.com

Rates under 4% came and went during the Covid pandemic, but home prices soared. Here's what buyers and sellers face as the housing season ramps up.

Cidara Therapeutics Inc

7d ago, source: U.S. News & World Report

These dividend stocks should prosper regardless of what happens with interest rates in 2024.

Cidara Therapeutics Inc CDTX

1mon ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...